Life Science REIT Dividends and Buybacks
Dividend criteria checks 2/6
Life Science REIT is a dividend paying company with a current yield of 5.41% that is well covered by earnings.
Key information
5.4%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | 6.8% |
| Dividend Growth | 35.6% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | UK£0.020 |
| Payout ratio | 59% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: LABS has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: LABS's dividend payments have increased, but the company has only paid a dividend for 3 years.
Dividend Yield vs Market
| Life Science REIT Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (LABS) | 5.4% |
| Market Bottom 25% (GB) | 2.1% |
| Market Top 25% (GB) | 5.9% |
| Industry Average (Health Care REITs) | 7.8% |
| Analyst forecast (LABS) (up to 3 years) | 6.8% |
Notable Dividend: LABS's dividend (5.41%) is higher than the bottom 25% of dividend payers in the UK market (2.11%).
High Dividend: LABS's dividend (5.41%) is low compared to the top 25% of dividend payers in the UK market (5.88%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (59.4%), LABS's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: LABS is paying a dividend but the company has no free cash flows.